Edition:
United States

Ligand Pharmaceuticals Inc (LGND.OQ)

LGND.OQ on NASDAQ Stock Exchange Global Market

221.09USD
13 Jul 2018
Change (% chg)

$0.36 (+0.16%)
Prev Close
$220.73
Open
$220.99
Day's High
$223.84
Day's Low
$220.99
Volume
43,941
Avg. Vol
110,847
52-wk High
$226.23
52-wk Low
$115.52

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 56.16 1.826
FY 2017 Dec '17 50.46 -0.332
Sep '17 33.38 0.358
Jun '17 28.00 0.261
Mar '17 29.27 0.221
FY 2016 Dec '16 38.19 -0.150
Sep '16 21.62 0.046
Jun '16 19.52 -0.296
Mar '16 29.65 0.264
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 3 41.28 41.77 40.60 --
Quarter Ending Dec-18 3 47.71 49.00 46.42 --
Year Ending Dec-18 4 216.58 228.90 184.25 174.85
Year Ending Dec-19 5 202.83 222.69 185.75 220.91
Earnings (per share)
Quarter Ending Sep-18 2 1.04 1.05 1.04 0.97
Quarter Ending Dec-18 2 1.28 1.30 1.26 1.22
Year Ending Dec-18 3 5.87 6.25 5.20 3.90
Year Ending Dec-19 5 5.55 5.90 4.88 5.22
LT Growth Rate (%) 3 31.67 40.00 25.00 30.00
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 104.66 214.97 33.20
P/E High - Last 5 Yrs. 256.07 284.72 47.16
P/E Low - Last 5 Yrs. 10.01 97.29 25.03
Beta 0.93 0.77 0.82
Price to Sales (TTM) 28.03 251.09 8.07
Price to Book (MRQ) 9.47 21.04 4.28
Price to Tangible Book (MRQ) 28.38 27.67 6.02
Price to Cash Flow (TTM) 73.03 128.42 22.38
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.72
Dividend Yield - 5 Year Avg -- 0.21 1.46
Dividend 5 Year Growth Rate -- 2.26 -6.51
Payout Ratio(TTM) 0.00 81.48 47.13

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 91.88 33.21 6.45
Sales (TTM) vs TTM 1 Yr. Ago 54.70 147.67 12.44
Sales - 5 Yr. Growth Rate 35.07 30.72 7.73
EPS (MRQ) vs Qtr. 1 Yr. Ago 727.49 -74.82 45.89
EPS (TTM) vs TTM 1 Yr. Ago 1,277.59 -- --
EPS - 5 Yr. Growth Rate -- 47.09 7.99
Capital Spending - 5 Yr. Growth Rate 29.37 42.70 7.69

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.37 1.72 2.57
Current Ratio (MRQ) 1.41 6.59 3.65
LT Debt to Equity (MRQ) 0.00 23.42 13.21
Total Debt to Equity (MRQ) 45.77 27.63 17.39
Interest Coverage (TTM) 1.15 -148.17 35.20

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 96.54 56.05 55.10
Gross Margin - 5 Yr. Avg. 92.74 53.56 53.12
EBITD Margin (TTM) 64.04 -- --
EBITD - 5 Yr. Avg 48.19 -181.19 15.68
Operating Margin (TTM) 56.49 -954.02 -0.51
Operating Margin - 5 Yr. Avg. 46.39 -194.86 10.86
Pre-Tax Margin (TTM) 63.31 -849.49 1.29
Pre-Tax Margin - 5 Yr. Avg. 27.79 -199.42 11.00
Net Profit Margin (TTM) 31.40 -840.78 -2.00
Net Profit Margin - 5 Yr. Avg. 59.09 -197.22 7.35
Effective Tax Rate (TTM) 50.40 14.88 20.80
Effective Tax Rate - 5 Yr. Avg. -112.64 19.11 24.26

Efficiency

  Company industry sector
Revenue/Employee (TTM) 4,307,462 23,460,657 746,903,749
Net Income/Employee (TTM) 1,352,641 -801,365 87,147,894
Receivable Turnover (TTM) 7.61 17.81 5.99
Inventory Turnover (TTM) 0.64 2.84 3.70
Asset Turnover (TTM) 0.24 0.48 0.88

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 7.62 3.19 10.49
Return on Assets - 5 Yr. Avg. 13.87 2.93 11.10
Return on Investment (TTM) 11.59 -3.79 13.23
Return on Investment - 5 Yr. Avg. 21.13 2.73 14.34
Return on Equity (TTM) 12.14 -5.32 15.28
Return on Equity - 5 Yr. Avg. 30.07 -3.26 15.70
  1 Year 3 Year 5 Year
Sales % 29.48 29.79 35.07
EPS (TTM) % 570.59 -1.59 --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Ligand Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 419
Total Shares Held: 24,380,808
3 Mo. Net Change: -98,152
# New Positions: 7
# Closed Positions: 3
# Increased Positions: 16
# Reduced Positions: 15
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.